Cod-Liver Oil Improves Metabolic Indices and Hs-CRP Levels in Gestational Diabetes Mellitus Patients: A Double-Blind Randomized Controlled Trial
Overview
Affiliations
Objective: To investigate the effects of cod-liver oil on metabolic status and high-sensitivity C-reactive protein (hs-CRP) in patients with gestational diabetes mellitus (GDM).
Methods: This study was a randomized, double-blinded, placebo-controlled trial with the allocation ratio of 1 : 1. The contents of EPA and DHA in cod-liver oil were measured using a gas chromatograph. A total of 550 GDM patients were randomly divided into the intervention group (cod-liver oil) and the control group (placebo, mineral oil), and both groups were given regular dietary care. Glycosylated hemoglobin A1c (HbA1c), fasting plasma glucose (FPG), 2-hour plasma glucose (2hPG), lipid profiles, homeostatic model assessment insulin resistance (HOMA-IR), and hs-CRP were measured. Primary outcomes were different in HbA1c, FPG, 2hPG, and HOMA-IR between the two groups after 4-week randomization. Secondary outcomes were the blood glucose levels and perinatal complications (pregnancy-induced hypertension, polyhydramnios, premature delivery, postpartum hemorrhage, postpartum infection, premature rupture of membranes, and cesarean section) between the two groups before and after 12-16 weeks of cod-liver oil intervention from middle pregnancy to late pregnancy.
Results: EPA and DHA were the main components of cod-liver oil with 76 mg/mL and 150 mg/mL, respectively. There was no significant difference for primary outcomes in the levels of HbA1c, FPG, 2hPG, HOMA-IR, and lipid profiles between the two groups ( > 0.05). For the secondary outcomes, the levels of HbA1c, FPG, 2hPG, triglyceride (TG), total cholesterol (TC), low-density lipoprotein cholesterol ratio (LDL-C), HOMA-IR, and hs-CRP in the intervention group were significantly lower than those in the control group ( < 0.05). The incidence of perinatal complications in the intervention group was lower than that in the control group too ( < 0.05).
Conclusions: Cod-liver oil consumption effectively reduced the levels of blood glucose, lipid levels, hs-CRP, and HOMA-IR and the incidence of perinatal complications.
Fatty Acid Metabolism Disruptions: A Subtle yet Critical Factor in Adverse Pregnancy Outcomes.
Cao X, Li M, Shao C, Shi J, Zhang T, Xie F Int J Biol Sci. 2024; 20(15):6018-6037.
PMID: 39664564 PMC: 11628336. DOI: 10.7150/ijbs.103404.
Liang C, Lu Y, Luo X, Weng F Infect Drug Resist. 2024; 17:3507-3517.
PMID: 39157744 PMC: 11328849. DOI: 10.2147/IDR.S474453.
Bayram S, Kiziltan G Curr Nutr Rep. 2024; 13(3):527-551.
PMID: 39031306 PMC: 11327211. DOI: 10.1007/s13668-024-00561-9.
Optimization and preparation of a compound cod liver oil film former agent: an orthogonal design.
He Y, Zhang Y, Li Z Front Pharmacol. 2024; 15:1296448.
PMID: 38495097 PMC: 10940503. DOI: 10.3389/fphar.2024.1296448.
DHA supplementation and pregnancy complications.
Jiang Y, Chen Y, Wei L, Zhang H, Zhang J, Zhou X J Transl Med. 2023; 21(1):394.
PMID: 37330569 PMC: 10276458. DOI: 10.1186/s12967-023-04239-8.